<DOC>
	<DOC>NCT01346930</DOC>
	<brief_summary>The MUSIC OL study is an open-label extension study, in which all eligible patients having completed the double-blind AC-055B201/MUSIC study as scheduled receive macitentan 10 mg once daily. The study objective is to assess the long-term safety and tolerability of macitentan in patients with idiopathic pulmonary fibrosis (IPF).</brief_summary>
	<brief_title>Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Macitentan</mesh_term>
	<criteria>Signed informed consent prior to initiation of any studyrelated procedure. Patients with IPF and having completed the doubleblind AC055B201/MUSIC study as scheduled, i.e., having remained in the study until the sponsordeclared endofstudy (EOS), whether or not study treatment was prematurely discontinued. Women of childbearing potential must have a negative pretreatment serum pregnancy test and must use a reliable method of contraception during study treatment and for at least 28 days after study treatment termination. Any major violation of protocol AC055B201/MUSIC. Premature discontinuation of study treatment during the AC055B201/MUSIC study due to an adverse event (AE) assessed as related to the use of macitentan, excluding events of IPF worsening. Pregnancy or breastfeeding. AST and/or ALT &gt; 3 times the upper limit of the normal range. Any known factor or disease that might interfere with treatment compliance, study conduct or interpretation of the results, such as drug or alcohol dependence or psychiatric disease. Known hypersensitivity to drugs of the same class as macitentan, or any of the excipients.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Idiopathic pulmonary fibrosis</keyword>
	<keyword>IPF</keyword>
	<keyword>pulmonary fibrosis</keyword>
</DOC>